Advanced Heart Failure Cardio-Oncologist @MDAnderson. NYer at ❤️. Tweets = my own.
Joined December 2011
- Tweets 207
- Following 452
- Followers 359
- Likes 598
30 Photos and videos
Pinned Tweet
14 Feb 2022
Early RV support can save lives post-VAD. Proud to lead this work from @MonteHeart @OhioStateHeart @HMethodistCV RVF Consortium Collab. @AshrithGuhaMD @hfdocbhimaraj @bhtrachtenberg @HMHCardioFellow
Is the RV borderline at the time of LVAD? Concomitant RV acute MCS support w/ LVAD insertion was associated with lower mortality (HR 0.45 [95% CI 0.26-0.80], p = 0.01) in multivariable model. @SalKumarMD provide important insights on #EarlyRVsupport #LVAD jhltonline.org/article/S1053…
5
10
50
Salil Kumar, MD retweeted
Imaging of Myocardial Carcinoid Metastasis sciencedirect.com/science/ar…
Excited to share our work in #CardioOnc @UTMDAnderson @anita_deswal @cezar_ciliescu @EKoutroumpakis @LYnalvez @SalKumarMD @HJRyooAli @ihab_hamzeh @PalaskasN @JACCJournals #JACCCaseReports
8
12
712
Salil Kumar, MD retweeted
20 Jun 2025
Fantastic grand round talk on check point inhibitors myocarditis by Dr Palaskas.@PalaskasN
2
6
321
Salil Kumar, MD retweeted
Fabulous presentation #ACC25 by @PatrikVan16247, a medical student from the University of Barcelona who worked with us @MDAndersonNews over the summer! Still a lot to be learnt about radiation-induced carotid vascular injury among survivors of head and neck cancer!
4
16
1,056
Salil Kumar, MD retweeted
31 Mar 2025
@anita_deswal leading our great team @MDAndersonNews #CardioOncology @ #ACC25 great science and amazing #cardiology family. The best work family
5
28
4,528
Salil Kumar, MD retweeted
8 Nov 2024
Starting Day 2! @ACCinTouch Clinical Trials Research: Upping Your Game @pamelasdouglas @TYWangMD @_WayneBatchelor @MelvinEchols9
2
12
60
7,885
21 Jun 2024
An inspiring 2 days at the Heart House meeting incredible people at #ACCCTR. Thanks to @MDAndersonNews @anita_deswal for the support!
20 Jun 2024
@ACCinTouch #ACCCTR 2024-24 Clinical Trials Research cohort and faculty at Heart House! @pamelasdouglas @MelvinEchols9 @TYWangMD @_WayneBatchelor @DrLaPrincess @ShashankSinhaMD #thefaceofcardiology
1
14
701
Salil Kumar, MD retweeted
30 Nov 2023
It was such a pleasure and delighted to have this conversation with Dr. Quinones.
11.28.23 CV Live: Cardio Fellow Book Presentation - Quinones/Toro | 11.2... youtube.com/live/_iY3cjsIL-s… via @YouTube
1
1
17
1,502
Salil Kumar, MD retweeted
18 Jun 2023
cardiogenicshocksummit.org/
Tick tock, tick tock don't miss your spot. Chat GPT says: In a symposium on cardiogenic shock, Experts gather to unlock, The secrets of the heart, And how to restart, When it's failing, beating, and in shock. @NavinKapur4 @ShashankSinhaMD @manreetkanwar
4
12
3,513
Salil Kumar, MD retweeted
7 May 2023
Often we get a consult for RHC on AHF pt and elevated HCO3 diuretic resistance with believe pt must be intravasc dry, but we find MAP, RAP, PCWP well elevated. Not intravascular dry but proximal nephron NaHCO3 retention is the cause of the diuretic resistance @RyanTedfordMD
2
5
30
4,456
Salil Kumar, MD retweeted
4 May 2023
1
33
124
18,286
22 Apr 2023
Grateful to present our work at #ISHLT2023 on sHK risk stratification. It’s time to implement a safety net policy for heart tx recipients and save kidney grafts! @AshrithGuhaMD @hfdocbhimaraj @mahwash_kassi @bhtrachtenberg @HMHCardioFellow
3
2
31
1,935
Salil Kumar, MD retweeted
4 Apr 2023
Please read our letter to the federal trade commission to ban all noncompetes. Please also share to create a groundswell. Letter attached here ⬇️ @APKithcartMDPhD @yourheartdoc1 @CMichaelGibson @djc795 @stentdoc1 @GiorgioMedranda @BinitaShahMD @EugeniaGianos @ajaykirtane
4 Apr 2023
Our letter to the FTC o/b/o @Cardiology professionals:
"While [noncompete] clauses may be beneficial to employers, they can be detrimental to patients who rely on their healthcare providers and continuity of care for life-saving and timely treatments and procedures..."
🧵 1/2
4
39
98
31,709
7 Mar 2023
Thankful to have trained @HMethodistCV and learned ACHD from amazing physicians @valeriaduarteMD and @HuieLin - an absolute highlight of the last 4 years. Thank you both for your mentorship and sponsorship!
7 Mar 2023
1
18
2,753
Salil Kumar, MD retweeted
4 Mar 2023
2
6
27
6,488
4 Mar 2023
Come visit our stellar lineup of RV recovery faculty! #RVRecovery #ACC23 @HMHCardioFellow @HMethodistCV
4 Mar 2023
🔊Attention #ACC23 attendees. This Monday at 8:30 - join our quest to save the 🔥failing right ventricle🔥On this mission: @RichKrasuskiMD @ralogon @SalKumarMD @elsisi96 @PeiNiJone @manreetkanwar William Auger - Juan Crestanelly - Zach Steinberg
1
3
539
Salil Kumar, MD retweeted
15 Feb 2023
Join us tomorrow at 8 am CST to learn from one of the greatest national experts in Congenital Heart Disease! Link to watch live👇 @mauriziobrighe3 @AkilaBersali @gab_liberato @laithalsh @SaurbhRajpal @stephgaydos @DrTonyPastor
Join us Feb. 16 for a Grand Rounds conference featuring Stephen P. Sanders, MD, presenting “Single Ventricle Hearts: Anatomy and Palliation”. Watch LIVE: bit.ly/GR021623. #CardioEd #CardioTwitter
1
3
13
1,526
Salil Kumar, MD retweeted
15 Feb 2023
Many congratulations to these stellar incoming chief fellows @smitha_narayana and @nbharat89!!
You will no doubt continue to be the formidable, caring, innovative leaders for this program. Can’t wait to see what you both come up with!!
#ACCFIT #AHAFIT #CardioTwitter
5
8
52
14,451
Salil Kumar, MD retweeted
MMI Conference as Dr. Mahwash Kassi (@mahwash_kassi) and Dr. Su Min Chang present “Imaging the Patient With LVAD: From Bedside to Echo to CTA x.com/i/broadcasts/1jMKgLZgR…
1
1
2
588
Salil Kumar, MD retweeted
17 Jan 2023
Announcing Bradley Z. Naifeh Amyloidosis Conference. Attend in person for best yield (virtual available). It's a multidisciplinary panel of speakers to focus on the broad organ involvement. #BZNAmyloidosis @Amyloidosisfdn @AmyloidosisDay @Amyloidosis_ARC @AmyloidosisSupp
3
7
22
3,687
Join @DeBakeyCVedu on Saturday Feb 4 at the 8th Annual Houston Heart Failure Summit where @robmentz and @MarkDrazner will headline discussions on the latest in heart failure management such as this! @HFSA @HMHCardioFellow @HMethodistMD Register: learn.houstonmethodist.org/h…
GLP-1R agonists & SGLT2 inhibitors are recommended first-line therapies for type 2 diabetes in patients with increased CV risk. Glucocentric Drugs in CV Disease Protection & Heart Failure @drtalhakhawaja @gcfmd @virani_md @JavedButler1
#DeBakeyCVJournal
doi.org/10.14797/mdcvj.1155
2
5
2,193